Clin2
NCT04189822Possibly a fitEnrolling by invitation

Heart rhythm genetic registry and blood sample bio bank

Sudden Cardiac ArrestSudden Arrhythmic Death SyndromeArrhythmogenic Right Ventricular Cardiomyopathy (ARVC)Long QT Syndrome (LQTS)Hypertrophic Cardiomyopathy (HCM)Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

Part of Genetic & congenital, Heart & circulation clinical trials.

This study is building a Canadian database and tissue/blood bank for people and families with inherited heart rhythm conditions (and some inherited heart muscle diseases). It collects consented health and genetic information to help researchers better understand who is at risk and how these conditions work.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
10,000 people
Ages
Any age
Study type
Observational

Who can take part

  • You (or your legal representative) must understand the study and willingly sign consent.
  • You have a known inherited heart rhythm condition or a close family member with one (for example Long QT, Short QT, CPVT, Brugada, ARVC, or certain familial conduction disorders).
  • You may qualify as a person who is a carrier of a gene variant linked to an inherited heart rhythm or cardiomyopathy risk.
  • You may qualify through a family blood relative: a first-degree relative (parent, child, sibling) with a known diagnosis, or a second-degree relative when screening the person in between isn’t possible.
  • If you are being referred for a heart muscle condition, it needs to be a Mendelian (inherited) type like hypertrophic cardiomyopathy, inherited dilated cardiomyopathy, or left ventricular non-compaction.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03049254Recruiting
Registry and blood/tissue study for certain sudden heart death causes

This study builds a registry and collection of samples to better understand families affected by sudden heart death and related heart rhythm problems that are not clearly caused by a heart attack. It may help researchers identify patterns and improve future care, and it offers a way for patients and families to contribute to research.

Rochester, Minnesota
NCT02413450Enrolling by invitation
Using patient DNA cells to study inherited heart rhythm risks

This study uses your blood or genetic information to make “iPS cells,” lab-grown cells that can help researchers study inherited heart rhythm problems like LQTS, Brugada syndrome, CPVT, or early repolarization syndrome. It may help improve understanding of why these rhythms happen and guide future treatments.

Baltimore, Maryland
NCT07014579Not yet recruiting
Using heart electrical signals to study treatments for dangerous heart rhythms in active people

This study looks at how the heart's electrical signals can help doctors understand if treatments prevent dangerous heart rhythms in active people. It involves people with or without heart devices like ICDs or pacemakers, and may help improve care for active individuals with heart conditions.

Leicester, Leicestershire
NCT03880708Recruiting
Registry for inherited dangerous heart rhythm conditions

This study is a heart rhythm registry for people with inherited conditions that can cause abnormal heart beats. By collecting health and testing information, researchers hope to better understand these conditions and improve care.

Beijing, Beijing Municipality
NCT00921986Recruiting
Store heart rhythm samples for arrhythmia research

This study builds a bank of stored heart rhythm-related samples so researchers can study different heart rhythm problems. It may help you or your family contribute to future testing and better care for arrhythmias.

Cleveland, Ohio
NCT07688200Not yet recruiting
Tracking heart rhythms and complications in arrhythmogenic cardiomyopathy

This study is a registry that collects information from people with arrhythmogenic cardiomyopathy who have an ICD. The goal is to learn more about the condition, its heart rhythm complications, and how the ICD works, which may help improve future care.

Hear when a new Sudden Cardiac Arrest trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.